Twist Bioscience Corp Annual Share-based Payment Arrangement, Expense in USD from 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Twist Bioscience Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2024.
  • Twist Bioscience Corp Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $12M, a 8.81% increase year-over-year.
  • Twist Bioscience Corp Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $51.9M, a 19% increase year-over-year.
  • Twist Bioscience Corp annual Share-based Payment Arrangement, Expense for 2024 was $50.9M, a 68.2% increase from 2023.
  • Twist Bioscience Corp annual Share-based Payment Arrangement, Expense for 2023 was $30.3M, a 61.7% decline from 2022.
  • Twist Bioscience Corp annual Share-based Payment Arrangement, Expense for 2022 was $79M, a 114% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $50.9M +$20.6M +68.2% Oct 1, 2023 Sep 30, 2024 10-K 2024-11-18
2023 $30.3M -$48.8M -61.7% Oct 1, 2022 Sep 30, 2023 10-K 2024-11-18
2022 $79M +$42M +114% Oct 1, 2021 Sep 30, 2022 10-K 2024-11-18
2021 $37M +$19.9M +116% Oct 1, 2020 Sep 30, 2021 10-K 2023-11-21
2020 $17.1M +$5.93M +53.1% Oct 1, 2019 Sep 30, 2020 10-K/A 2023-06-05
2019 $11.2M +$8.21M +277% Oct 1, 2018 Sep 30, 2019 10-K 2021-11-23
2018 $2.96M +$1.07M +56.6% Oct 1, 2017 Sep 30, 2018 10-K 2020-11-27
2017 $1.89M Oct 1, 2016 Sep 30, 2017 10-K 2019-12-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.